Close
ACHEMA MIDDLE EAST 2026

Edge Therapeutics begins enrolment in second cohort of EG-1962 Phase I/II trial for aSAH

US-based biotechnology firm Edge Therapeutics has started enrolling patients in the second group of a multicenter, randomised, controlled, open-label, Phase I/II NEWTON trial of...

State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment

There are 5 million persons suffering from asthma in Great Britain and despite medication, half a million of these persons have symptoms which limit...

Arena begins Phase Ib trial of APD334 to treat autoimmune diseases

US-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate that targets the sphingosine...

Boston Therapeutics begins Phase IIb Sugardown trial for type 2 diabetes patients

US-based Boston Therapeutics (BTI) has started a Phase IIb clinical trial SD-002 to evaluate the efficacy and safety of Sugardown in patients with type...

Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer

Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy product candidate CV-301 for...

Abbvie starts Phase III trial of lung cancer drug veliparib

US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) polymerase (PARP) inhibitor 'veliparib...

Health ministry turns down SLAs’ demand for amending D&C Rules to define role of SLAs in monitoring clinical trials

3rd February 2014, India - The Union health ministry of India has turned down some of the state drug controllers' demand for an amendment...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...